Post by eisq - Outsourcing-Beratung

𝘠𝘰𝘶𝘳 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘱𝘢𝘳𝘵𝘯𝘦𝘳 𝘱𝘳𝘰𝘮𝘪𝘴𝘦𝘴 𝘢𝘨𝘪𝘭𝘪𝘵𝘺. 𝘠𝘰𝘶𝘳 𝘳𝘦𝘨𝘶𝘭𝘢𝘵𝘰𝘳 𝘥𝘦𝘮𝘢𝘯𝘥𝘴 𝘱𝘳𝘰𝘰𝘧 𝘰𝘧 𝘴𝘵𝘢𝘣𝘪𝘭𝘪𝘵𝘺. Anyone responsible for outsourcing in pharma IT knows this tension — and knows it cannot be argued away. Bernhard Gandolf worked through exactly this with Martin Ganser, Chiesi Group. Three things we take from the conversation: 💊 Outcome models shift responsibility — not liability. In validated environments, you still need to explain how a result was produced. "We delivered" is not enough. ⚖️ SLAs are not a relic. They are the language regulators, auditors, and quality systems understand. Remove them and you create blind spots. 🔬 The right question is not outcome vs. SLA. It's: which processes are stable enough for outcome orientation — and where does a measurable quality framework remain non-negotiable? 📋 Many providers sell agility that works in their world. Not yours. You find that out at the next audit — not at contract signing. 🔗 Link in the comments. #PharmaOutsourcing #VendorManagement #OutsourcingGovernance #LifeSciences #Compliance

Video Content